Progressive muscular atrophy (PMA) is clinically characterized solely by signs of lower motor neuron dysfunction, so patients with this condition are commonly excluded from ALS clinical trials.

DySMA, to assess swallowing in children with SMA while undergoing treatment, was applied to healthy children to facilitate ...

Despite significant advancements in spinal muscular atrophy (SMA) management, unmet needs persist, especially for patients ...

Spinal muscular atrophy (SMA) is a progressive neurodegenerative disorder set in motion before birth. Scientists at St. Jude Children's Research Hospital led the first in utero treatment of SMA ...

Multiple system atrophy (MSA) refers to a group of progressive neurodegenerative disorders that ... and slurred and low-volume speech. Neck and trunk muscle rigidity or weakness may result in abnormal ...

Those with spinal muscular atrophy can get emotional support by building an SMA support system that includes SMA communities ...

ISLAMABAD: A five-year plan to eradicate spinal muscular atrophy (SMA), a genetic disorder causing progressive muscle weakness that was once a leading cause of infant mortality has been launched.

22. Apitegromab is an investigational treatment aimed at improving motor function for people living with spinal muscular atrophy. Scholar Rock said it has also submitted and received validation ...

Freddie-Shaun Dahill Egan was born with spinal muscular atrophy (SMA), a rare genetic condition that causes progressive ...